CTEV
Claritev Corporation
NYSE: CTEV · HEALTHCARE · HEALTH INFORMATION SERVICES
$24.33
+5.51% today
Updated 2026-04-30
Market cap
$403.98M
P/E ratio
—
P/S ratio
0.42x
EPS (TTM)
$-17.30
Dividend yield
—
52W range
$12 – $74
Volume
0.2M
Claritev Corporation (CTEV) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $292.30M | $284.31M | $377.37M | $404.69M | $372.36M | $171.72M | $107.62M | $117.32M |
| Capital expenditures | $63.56M | $66.41M | $70.81M | $84.59M | $89.73M | $108.85M | $118.12M | $129.60M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $4.72M | $-14.88M | $406.05M | $18.01M | $16.74M | $18.02M | $26.64M | $27.82M |
| Free cash flow | $228.75M | $217.90M | $306.56M | $320.10M | $282.63M | $62.87M | $-10.51M | $-12.28M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |